NVOS - רווח למניה בשנים עשר החודשים האחרונים Novo Integrated Sciences Corp

The EPS TTM history for Novo Integrated Sciences (NVOS) demonstrates the impact of demand for affordable preventive medicine and the expansion of the patient base, with the value holding at -1.33. The business relies on a network of North American clinics and logistics centers. Efficiency is increasing through the implementation of AI diagnostics and digital platforms that automate primary screenings.
פילוחים אנליטיים ודוחות נתונים של חברת Novo Integrated Sciences (NVOS)

Net income per share over 12 months measures the business's equity income, excluding the impact of the total issuance volume. By analyzing the rolling 12-month EPS chart, an investor identifies the exact dates of a fundamental trend reversal. The daily calculation of this metric makes it sensitive to any changes in net income. For Novo Integrated Sciences (NVOS), this indicator reflects the efficiency of the synergy between medicine and IT. The stable margins of the company's services ensure predictable dynamics for this metric.